Reps. Doris Matsui, D-CA, and Bill Johnson, R-OH, renew their push for a national age-18 requirement for buying OTC medicines containing the cough suppressant dextromethorphan, which is abused by some teenagers to get high. The House members on Jan. 30 introduced the DXM Abuse Prevention Act of 2019, H.R. 863, legislation that they also sponsored during the previous session of Congress.
Health Market News: DXM Sales Age-Restriction Bill Filed, E-Cigarettes Top NRTs In UK Trial
Resp. Matsui, Johnson again introduce bill for national age-18 requirement for OTC DXM sales; E-Cigarettes top NRTs for smoking cessation efficacy in UK trial.
More from Legislation
More from Policy & Regulation
• By
A round-up of the latest industry moves in Europe: Pharma Deutschland elects board of new Brussels operation; MHRA's new CEO gets to work; Futura names non-executive director.
• By
“If this doesn’t get reauthorized, look at the number of the ingredients out there, the number of products, what would happen all those products out there for the consumer, on that shelf, in the drugstore or someplace?” says Rep. Bob Latta during House hearing.
• By
Energy and Commerce Health Subcommittee Democrats focus on criticizing HHS Secretary Kennedy’s RIF announcement, including 3,500 FDA jobs among cuts across HHS agencies. “If we reauthorize it, will it continue?” Texas representative Lizzie Fletcher asks of OMUFA.